Yale, Biohaven Win $4M In Biotech Trade Secret Trial
By Ivan Moreno · July 27, 2026, 5:19 PM EDT
A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million after finding that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with co-defendant...
To view the full article, register now.